article · Journal of Global Medicine
Background Although the COVID-19 epidemic seems to have ceased, with only few new sporadic cases seen, reports of new strains of the virus could lead to a resurgence and death. Hence, this study identified the factors influencing COVID-19 treatment outcomes among patients in Ibadan, Nigeria. Objective To identify the determinants of COVID-19 treatment outcomes among patients admitted at the Infectious Disease Centre, Olodo, Ibadan, Nigeria. Method A facility-based retrospective study was conducted. A review of the records of all cases (932) of laboratory confirmed COVID-19 positive patients, who received treatment between April 2020 and January 2022 at the Centre was conducted. Data was analysed at the level of significance of 5%. Results The mean age (S.D.) of the patients was 36.97 (14.6) years, while the mean number of days on admission was 14.87 (11.33) days. Most were males (66.7%). Many (51.5%) were symptomatic at admission, 4% had co-morbidities. The other disease conditions present included obesity, asthma, diabetes and hypertension. At admission, 45.8% had a low body temperature and about a quarter (29.7%) had a high respiratory rate. More than half (63.3%) had a high lymphocyte count, while 41.1% had low neutrophil count. The case fatality rate was 3.3%. Patients’ occupation (OR = 0.56, p = 0.01), pulse rate (OR = 1.00, p = 0.00), blood pressure (OR = 2.97, p = 0.007) and oxygen saturation (OR = 0.05, p = 0.00) were significantly (p <0.05) associated with COVID-19 treatment outcomes. Conclusion Patients’ occupation was a positive predictor of treatment outcomes, hence patients’ occupation should be considered in the classification of disease severity of the infection and subsequent treatment.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.51496/jogm.v4.139
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.